The finding that AGO2 can shift into the nucleus of tumor cells in a subset of patients suggests that the regulation of miRNA activity by changing the localization of core RISC machinery may contribute to cellular processes within some tumors and should be considered in studies aimed at examining the impact of miRNA action in human cancers. The gene discussed is AGO2; the disease is cancer.